Vaxfab Reports Q3 Loss Amid Auditor Disclaimer

Vaxfab Enterprises Ltd recorded a consolidated net loss of ₹323.52 lakh (₹3.24 crore) for the third quarter of fiscal year 2026. This stands in contrast to its standalone operations, which posted a net profit of ₹22.98 lakh (₹0.23 crore) for the same period. The company's consolidated revenue from operations reached ₹1566.29 lakh (₹15.66 crore).

The most significant development in the company's unaudited financial results is the auditor's report, which includes a disclaimer of opinion and multiple qualifications.

Impact of Auditor's Disclaimer

An auditor's disclaimer signifies that the auditors were unable to gather enough appropriate evidence to form an opinion on the financial statements. This lack of an opinion directly impacts the reliability and credibility of the figures Vaxfab has reported.

For investors and stakeholders who depend on audited financial statements for making crucial decisions, a disclaimer suggests that there may be significant errors or fundamental problems within the company's accounting and record-keeping practices.

Company Background

Vaxfab Enterprises primarily operates in the manufacturing and trading of textiles and related products. The company's operations are conducted through its subsidiary, Eklingji Tradelink Private Limited.

Challenges Ahead for Vaxfab

Shareholders now face increased uncertainty about the company's actual financial health. The firm is likely to come under intense scrutiny from regulatory bodies and stock exchanges.

Obtaining future funding or credit may become considerably more difficult without a clean audit opinion. Additionally, investors may call for immediate and thorough explanations from the company's management.

Specific Audit Issues Detailed

The auditors noted they could not obtain sufficient appropriate evidence concerning several areas, including:

• Confirmations for trade receivables and payables, and outstanding tax compliance.
• The proper classification of creditors under the MSMED Act, 2006.
• Documentation for goods movement (inward/outward) and external confirmations for trade receivables and payables.
• Interest-free unsecured loans that lacked formal agreements.

Furthermore, the company did not recognize any provision for gratuity liability. An assessment for impairment of financial assets using the Expected Credit Loss (ECL) model was also not performed. Issues related to previous management transitions also hindered the ability to ensure compliance with Ind AS accounting standards.

Industry Comparison

Leading textile companies such as Raymond, Arvind Fashions, Trident, and Welspun India typically present their financial results with unqualified audit opinions. Vaxfab's situation, marked by an auditor's disclaimer, is unusual within the sector and points to potential weaknesses in its internal controls.

What Investors Are Watching

Key developments investors will monitor include:

• Vaxfab's detailed response and planned corrective actions concerning the auditors' qualifications.
• Any official clarifications issued by the stock exchanges or the Securities and Exchange Board of India (SEBI).
• The company's capability to secure a clean audit opinion in subsequent reporting periods.
• The stock price's movement and shifts in investor sentiment.
• Potential effects on ongoing business operations and existing partnerships.